Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the US.

Robst, John

Robst, John.

Affiliation

Robst J; Department of Mental Health Law and Policy, University of South Florida, Tampa, FL 33612, USA. jrobst@usf.edu

Pharmacoeconomics ; 30(5): 387-96, 2012 May.

Article in En | MEDLINE | ID: mdl-22316397

Subject(s)

Antipsychotic Agents/economics; Drug Utilization/economics; Medicaid/economics; Mood Disorders/economics; Schizophrenia/economics; Adolescent; Adult; Antipsychotic Agents/therapeutic use; Child, Preschool; Drug Therapy, Combination/economics; Female; Florida; Guideline Adherence/statistics & numerical data; Humans; Infant; Male; Managed Care Programs/economics; Middle Aged; Mood Disorders/drug therapy; Patient Compliance/statistics & numerical data; Schizophrenia/drug therapy; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Medicaid / Mood Disorders / Drug Utilization Type of study: Guideline Limits: Adolescent / Adult / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google